MOQ : 30 Piece(s)
Business Type : Exporter, Supplier, Retailer, Trader, Distributor
Product Details
| Type | Diabetic Medicines |
| Grade Standard | Medicine Grade |
| Form | Tablets |
| Function | Sugar Control |
| Country of Origin | India |
| Product Name | Brand Glyxambi Tablet |
| Salt Name | Empagliflozin+Linagliptin |
| Strength Available | 10mg+5mg and 25mg+5mg |
| Packing | 1x10 |
| Packing type | Box (Blister strips) |
| 1 Box contain | 90 pills |
| Manufacturer | Boehringer Ingelheim |
| Manufacturer Approved by | USFDA, UKMHRA, TGA and other Regulatory agency too |
| Storage | Store at room temperature (10-30°C) |
| Use | Helps control blood sugar levels. |
Additional Information
| Port | India |
| Payment Terms | T/T, Other |
| Delivery Time | Normal Shipping:- 12-25 working days and Premium Shipping:- 7-15 Working days |
| Packaging Details | Discreet Packing |
Preferred Buyer From
| Location | All Countries Except India |
Generic Name : Empagliflozin and linagliptin
Strength Available : 10mg+5mg) and (25mg+5mg)
Therapeutic use : Glyxambi is a combination of two drugs: empagliflozin and linagliptin are paired with these drugs. it is used for the regulation of elevated blood pressure in patients with type 2 diabetes with a proper diet and preparation regimen. high blood sugar management helps to reduce kidney injury, paralysis, issues with nerves, muscle weakness and problems with sexual activity. proper diabetes management will also reduce the chance of heart disease or stroke. empagliflozin functions by increasing the kidneys' elimination of sugar. linagliptin acts by rising the levels of so-called incretins in natural compounds. blood sugar is regulated by incretins, especially after a meal, which increase insulin release.
